These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 26087755)

  • 21. A single intra-articular injection of 2.0% non-chemically modified sodium hyaluronate vs 0.8% hylan G-F 20 in the treatment of symptomatic knee osteoarthritis: A 6-month, multicenter, randomized, controlled non-inferiority trial.
    Maheu E; Avouac B; Dreiser RL; Bardin T
    PLoS One; 2019; 14(12):e0226007. PubMed ID: 31821355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of a single intra-articular injection of 6 ml Hylan G-F 20 compared to placebo in Chinese patients with symptomatic knee osteoarthritis : C-SOUND study, a 26-week multicenter double-blind randomized placebo-controlled trial in China.
    Ke Y; Jiang W; Xu Y; Chen Y; Zhang Q; Xue Q; Lin J; Ngai W; Nian G; Fazeli MS; Xie Y; Zhu Z
    BMC Musculoskelet Disord; 2021 May; 22(1):428. PubMed ID: 33964907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan.
    Wobig M; Bach G; Beks P; Dickhut A; Runzheimer J; Schwieger G; Vetter G; Balazs E
    Clin Ther; 1999 Sep; 21(9):1549-62. PubMed ID: 10509850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee.
    Wobig M; Dickhut A; Maier R; Vetter G
    Clin Ther; 1998; 20(3):410-23. PubMed ID: 9663358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional outcome in knee osteoarthritis after treatment with hylan G-F 20: a prospective study.
    Goorman SD; Watanabe TK; Miller EH; Perry C
    Arch Phys Med Rehabil; 2000 Apr; 81(4):479-83. PubMed ID: 10768539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Safety of Hylan versus Hyaluronic Acid in the Treatment of Knee Osteoarthritis.
    Dai WL; Lin ZM; Guo DH; Shi ZJ; Wang J
    J Knee Surg; 2019 Mar; 32(3):259-268. PubMed ID: 29618143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy evaluation of highly purified intra-articular hyaluronic acid (Sinovial(®)) vs hylan G-F20 (Synvisc(®)) in the treatment of symptomatic knee osteoarthritis. A double-blind, controlled, randomized, parallel-group non-inferiority study.
    Pavelka K; Uebelhart D
    Osteoarthritis Cartilage; 2011 Nov; 19(11):1294-300. PubMed ID: 21875678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A second course of hylan G-F 20 for the treatment of osteoarthritic knee pain: 12-month patient follow-up.
    Waddell DD; Cefalu CA; Bricker DC
    J Knee Surg; 2005 Jan; 18(1):7-15. PubMed ID: 15742592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT-OARSI.
    Bellamy N; Bell MJ; Goldsmith CH; Pericak D; Walker V; Raynauld JP; Torrance GW; Tugwell P; Polisson R
    Osteoarthritis Cartilage; 2005 Feb; 13(2):104-10. PubMed ID: 15694571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of knee osteoarthritis: knee lavage combined with hylan versus hylan alone.
    Vad VB; Bhat AL; Sculco TP; Wickiewicz TL
    Arch Phys Med Rehabil; 2003 May; 84(5):634-7. PubMed ID: 12736873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of Hylan G-F 20 in shoulder osteoarthritis with an intact rotator cuff. Open-label prospective multicenter study.
    Noël E; Hardy P; Hagena FW; Laprelle E; Goebel F; Faure C; Favard L; Gaudin P; Christ R; Baudot C; Dietl J; Goupille P
    Joint Bone Spine; 2009 Dec; 76(6):670-3. PubMed ID: 19945321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open-label, multicentre, pilot study.
    Conrozier T; Bertin P; Mathieu P; Charlot J; Bailleul F; Treves R; Vignon E; Chevalier X
    Clin Exp Rheumatol; 2003; 21(5):605-10. PubMed ID: 14611109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial.
    Jüni P; Reichenbach S; Trelle S; Tschannen B; Wandel S; Jordi B; Züllig M; Guetg R; Häuselmann HJ; Schwarz H; Theiler R; Ziswiler HR; Dieppe PA; Villiger PM; Egger M;
    Arthritis Rheum; 2007 Nov; 56(11):3610-9. PubMed ID: 17968921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pain relief and improved physical function in knee osteoarthritis patients receiving ongoing hylan G-F 20, a high-molecular-weight hyaluronan, versus other treatment options: data from a large real-world longitudinal cohort in Canada.
    Petrella RJ; Wakeford C
    Drug Des Devel Ther; 2015; 9():5633-40. PubMed ID: 26508838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative efficacy and safety of two different molecular weight (MW) hyaluronans F60027 and Hylan G-F20 in symptomatic osteoarthritis of the knee (KOA). Results of a non inferiority, prospective, randomized, controlled trial.
    Maheu E; Zaim M; Appelboom T; Jeka S; Trc T; Berenbaum F; Maasalu K; Berenbaum F
    Clin Exp Rheumatol; 2011; 29(3):527-35. PubMed ID: 21722501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viscosupplementation with hylan G-F 20 (Synvisc): pain and mobility observations from 74 consecutive patients.
    Lee S; Park D; Chmell SJ
    J Knee Surg; 2004 Apr; 17(2):73-7. PubMed ID: 15124659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyaluronic acid for the treatment of knee osteoarthritis: long-term outcomes from a naturalistic primary care experience.
    Petrella RJ
    Am J Phys Med Rehabil; 2005 Apr; 84(4):278-83; quiz 284, 293. PubMed ID: 15785261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement in condition-specific and generic quality of life outcomes in patients with knee osteoarthritis following single-injection Synvisc: results from the LOBRAS study.
    Kearey P; Popple AE; Warren J; Davis T; Bellamy N;
    Curr Med Res Opin; 2017 Mar; 33(3):409-419. PubMed ID: 27848271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One-year follow-up showing effects of single intra-articular injection of hyaluronic acid (1,500-2,000 kDa) in symptomatic knee osteoarthritis.
    Migliore A; Frediani B; Gigliucci G; Anichini SE; Cassol M; Crimaldi S; De Lucia O; Iolascon G; Foti C
    J Biol Regul Homeost Agents; 2018; 32(6):1433-1441. PubMed ID: 30574747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy and safety of a single intra-articular injection of 2% hyaluronic acid plus mannitol in knee osteoarthritis over a 6-month period].
    Borrás-Verdera A; Calcedo-Bernal V; Ojeda-Levenfeld J; Clavel-Sainz C
    Rev Esp Cir Ortop Traumatol; 2012; 56(4):274-80. PubMed ID: 23594845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.